Penserra Capital Management LLC increased its holdings in abrdn Healthcare Investors (NYSE:HQH – Free Report) by 15.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,198,855 shares of the financial services provider’s stock after acquiring an additional 159,618 shares during the quarter. Penserra Capital Management LLC’s holdings in abrdn Healthcare Investors were worth $22,130,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also bought and sold shares of HQH. Eastern Bank purchased a new stake in abrdn Healthcare Investors in the third quarter worth about $30,000. Newbridge Financial Services Group Inc. purchased a new stake in shares of abrdn Healthcare Investors in the 2nd quarter worth approximately $34,000. Guerra Advisors Inc purchased a new stake in shares of abrdn Healthcare Investors in the 3rd quarter worth approximately $39,000. Geneos Wealth Management Inc. increased its position in abrdn Healthcare Investors by 9,232.3% during the 2nd quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider’s stock valued at $45,000 after buying an additional 2,862 shares in the last quarter. Finally, Colonial Trust Advisors purchased a new position in abrdn Healthcare Investors during the second quarter valued at $57,000. Institutional investors own 32.60% of the company’s stock.
abrdn Healthcare Investors Price Performance
abrdn Healthcare Investors stock opened at $19.31 on Wednesday. abrdn Healthcare Investors has a 12 month low of $13.77 and a 12 month high of $19.79. The business’s fifty day simple moving average is $19.10 and its two-hundred day simple moving average is $18.05.
abrdn Healthcare Investors Increases Dividend
abrdn Healthcare Investors Company Profile
abrdn Healthcare Investors (NYSE:HQH) is a closed-end management investment company that seeks long-term capital appreciation and current income by investing primarily in equity securities of companies operating in the healthcare sector. The fund’s portfolio generally comprises a diversified mix of domestic and international healthcare issuers, spanning pharmaceuticals, biotechnology, medical devices, healthcare services, and related industries.
The fund employs a fundamental, research-driven approach to select investments, focusing on companies with strong balance sheets, innovative product pipelines and the potential for sustainable revenue growth.
Featured Articles
- Five stocks we like better than abrdn Healthcare Investors
- [No Brainer Gold Play]: “Show me a better investment.”
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
Want to see what other hedge funds are holding HQH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for abrdn Healthcare Investors (NYSE:HQH – Free Report).
Receive News & Ratings for abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.
